Best Practices: Optimizing Care for People with Serious Mental Illness and Comorbid Diabetes

Overview

Journal Psychiatr Serv

Specialty Psychiatry

Date 2011 Sep 3

PMID 21885575

Citations 26

Authors

Martha Sajatovic

Neal V Dawson

Adam T Perzynski

Carol E Blixen

Christopher S Bialko

Christine L McKibbin

Mark S Bauer

Eileen L Seeholzer

Denise Kaiser

Edna Fuentes-Casiano

Affiliations

Soon will be listed here.

Abstract

Diabetes and obesity among patients with serious mental illness are common. Use of second-generation antipsychotics compounds risk, and widely prevalent unhealthy behaviors further contribute to negative outcomes. This column describes Targeted Training in Illness Management, a group-based psychosocial treatment that blends psychoeducation, problem identification, goal setting, and behavioral modeling and reinforcement. The intervention has been adapted to the primary care setting and is targeted at individuals with serious mental illness and diabetes. A key feature of the intervention is the use of peer educators with serious mental illness and diabetes to teach and model self-management. Promising results from a 16-week trial are reported.

Citing Articles

Non-Pharmacological Interventions for Type 2 Diabetes in People Living with Severe Mental Illness: Results of a Systematic Review and Meta-Analysis.

Ojo O, Kalocsanyiova E, McCrone P, Elliott H, Milligan W, Gkaintatzi E Int J Environ Res Public Health. 2024; 21(4).

PMID: 38673334 PMC: 11049919. DOI: 10.3390/ijerph21040423.

Interventions to Promote the Utilization of Physical Health Care for People with Severe Mental Illness: A Scoping Review.

Strunz M, Jimenez N, Gregorius L, Hewer W, Pollmanns J, Viehmann K Int J Environ Res Public Health. 2023; 20(1).

PMID: 36612457 PMC: 9819522. DOI: 10.3390/ijerph20010126.

Non-Pharmacological Integrated Interventions for Adults Targeting Type 2 Diabetes and Mental Health Comorbidity: A Mixed-Methods Systematic Review.

Tuudah E, Foye U, Donetto S, Simpson A Int J Integr Care. 2022; 22(2):27.

PMID: 35855093 PMC: 9248983. DOI: 10.5334/ijic.5960.

An interventional pilot of customized adherence enhancement combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania.

Mbwambo J, Kaaya S, Lema I, Burant C, Magwiza C, Madundo K BMC Psychiatry. 2022; 22(1):62.

PMID: 35086504 PMC: 8793204. DOI: 10.1186/s12888-022-03695-8.

A customized adherence enhancement program combined with long-acting injectable antipsychotic medication (CAE-L) for poorly adherent patients with chronic psychotic disorder in Tanzania: A pilot study methodological report.

Mbwambo J, Kaaya S, Lema I, Blixen C, Cassidy K, Levin J Heliyon. 2019; 5(6):e01763.

PMID: 31198864 PMC: 6556816. DOI: 10.1016/j.heliyon.2019.e01763.

References

Barnett A, Mackin P, Chaudhry I, Farooqi A, Gadsby R, Heald A . Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia. J Psychopharmacol. 2007; 21(4):357-73. DOI: 10.1177/0269881107075509. View

McKibbin C, Patterson T, Norman G, Patrick K, Jin H, Roesch S . A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res. 2006; 86(1-3):36-44. DOI: 10.1016/j.schres.2006.05.010. View

Faulkner G, Cohn T . Pharmacologic and nonpharmacologic strategies for weight gain and metabolic disturbance in patients treated with antipsychotic medications. Can J Psychiatry. 2006; 51(8):502-11. DOI: 10.1177/070674370605100805. View

Lee S, Choi E, Kwon J . A naturalistic multicenter trial of a 12-week weight management program for overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2008; 69(4):555-62. DOI: 10.4088/jcp.v69n0406. View

Chinman M, Rosenheck R, Lam J, Davidson L . Comparing consumer and nonconsumer provided case management services for homeless persons with serious mental illness. J Nerv Ment Dis. 2000; 188(7):446-53. DOI: 10.1097/00005053-200007000-00009. View